ZERO Biotech is led by a team of experienced industry veterans including experienced business leaders, physicians, radio-pharmacists, scientists and engineers.  The technology-first management team adds unique capabilities to tackle the anticipated R&D challenges involved in developing alternative medical isotope production methodology, namely, LINAC accelerator. In addition, the board of advisors is made up of world-renowned nuclear physics, nuclear medicine, oncology experts, providing specific industry insights and advisories to the management team to succeed at the global playing field.